Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016, Article ID 5389181, 14 pages
http://dx.doi.org/10.1155/2016/5389181
Research Article

miR-21 Reduces Hydrogen Peroxide-Induced Apoptosis in c-kit+ Cardiac Stem Cells In Vitro through PTEN/PI3K/Akt Signaling

1Department of Cardiology, Affiliated Hospital of Zunyi Medical College, Zunyi 563000, China
2Department of Anesthesiology, Zunyi Medical College, Zunyi 563000, China
3Guizhou Key Laboratory of Anesthesia and Organ Protection, Zunyi Medical College, Zunyi 563000, China

Received 7 April 2016; Revised 6 July 2016; Accepted 19 July 2016

Academic Editor: Qingping Feng

Copyright © 2016 Wenwen Deng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Mozaffarian, E. J. Benjamin, A. S. Go et al., “Heart disease and stroke statistics—2016 update: a report from the American Heart Association,” Circulation, vol. 133, no. 4, pp. e38–e360, 2016. View at Publisher · View at Google Scholar
  2. S. A. Fisher, D. Carolyn, M. Anthony, and M. R. Enca, “Meta-analysis of cell therapy trials for patients with heart failure,” Circulation Research, vol. 116, no. 8, pp. 1361–1377, 2015. View at Google Scholar
  3. K. U. Hong and R. Bolli, “Cardiac stem cell therapy for cardiac repair,” Current Treatment Options in Cardiovascular Medicine, vol. 16, no. 7, pp. 1–19, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. S. K. Sanganalmath and R. Bolli, “Cell therapy for heart failure: a comprehensive overview of experimental and clinical studies, current challenges, and future directions,” Circulation Research, vol. 113, no. 6, pp. 810–834, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. A. P. Beltrami, L. Barlucchi, D. Torella et al., “Adult cardiac stem cells are multipotent and support myocardial regeneration,” Cell, vol. 114, no. 6, pp. 763–776, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. C. Bearzi, M. Rota, T. Hosoda et al., “Human cardiac stem cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 35, pp. 14068–14073, 2007. View at Google Scholar
  7. X.-L. Tang, Q. Li, G. Rokosh et al., “Long-term outcome of administration of c-kitPOS cardiac progenitor cells after acute myocardial infarction: transplanted cells do not become cardiomyocytes, but structural and functional improvement and proliferation of endogenous cells persist for at least one year,” Circulation Research, vol. 118, no. 7, pp. 1091–1105, 2016. View at Publisher · View at Google Scholar
  8. R. Bolli, X.-L. Tang, S. K. Sanganalmath et al., “Intracoronary delivery of autologous cardiac stem cells improves cardiac function in a porcine model of chronic ischemic cardiomyopathy,” Circulation, vol. 128, no. 2, pp. 122–131, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. A. Linke, P. Müller, D. Nurzynska et al., “Stem cells in the dog heart are self-renewing, clonogenic, and multipotent and regenerate infarcted myocardium, improving cardiac function,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 25, pp. 8966–8971, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. K. M. Fischer, C. T. Cottage, W. Wu et al., “Enhancement of myocardial regeneration through genetic engineering of cardiac progenitor cells expressing Pim-1 kinase,” Circulation, vol. 120, no. 21, pp. 2077–2087, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. D. Angert, R. M. Berretta, H. Kubo et al., “Repair of the injured adult heart involves new myocytes potentially derived from resident cardiac stem cells,” Circulation Research, vol. 108, no. 10, pp. 1226–1237, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. X.-L. Tang, G. Rokosh, S. K. Sanganalmath et al., “Intracoronary administration of cardiac progenitor cells alleviates left ventricular dysfunction in rats with a 30-day-old infarction,” Circulation, vol. 121, no. 2, pp. 293–305, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Taghavi, T. E. Sharp, J. M. Duran et al., “Autologous c-Kit+ mesenchymal stem cell injections provide superior therapeutic benefit as compared to c-Kit+ cardiac-derived stem cells in a feline model of isoproterenol-induced cardiomyopathy,” Clinical and Translational Science, vol. 8, no. 5, pp. 425–431, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. R. Bolli, A. R. Chugh, D. D'Amario et al., “Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial,” The Lancet, vol. 378, no. 9806, pp. 1847–1857, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. J. H. van Berlo, O. Kanisicak, M. Maillet et al., “c-kit+ cells minimally contribute cardiomyocytes to the heart,” Nature, vol. 509, no. 7500, pp. 337–341, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. N. Tallini, S. G. Kai, M. Craven et al., “c-kit expression identifies cardiovascular precursors in the neonatal heart,” Proceedings of the National Academy of Sciences of the United States of America, vol. 106, no. 6, pp. 1808–1813, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Huang, H. Gu, Q. Yu, M. C. Manukyan, J. A. Poynter, and M. Wang, “Sca-1+ cardiac stem cells mediate acute cardioprotection via paracrine factor SDF-1 following myocardial ischemia/reperfusion,” PLoS ONE, vol. 6, no. 12, Article ID e29246, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. W. D. Gray, K. M. French, S. Ghosh-Choudhary et al., “Identification of therapeutic covariant microRNA clusters in hypoxia-treated cardiac progenitor cell exosomes using systems biology,” Circulation Research, vol. 116, no. 2, pp. 255–263, 2015. View at Publisher · View at Google Scholar · View at Scopus
  19. S. Hu, M. Huang, P. K. Nguyen et al., “Novel microRNA prosurvival cocktail for improving engraftment and function of cardiac progenitor cell transplantation,” Circulation, vol. 124, no. 11, pp. S27–S34, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. K. U. Hong, Q.-H. Li, Y. Guo et al., “A highly sensitive and accurate method to quantify absolute numbers of c-kit+ cardiac stem cells following transplantation in mice,” Basic Research in Cardiology, vol. 108, no. 3, article 346, pp. 1–10, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. K. U. Hong, Y. Guo, Q.-H. Li et al., “c-kit+ cardiac stem cells alleviate post-myocardial infarction left ventricular dysfunction despite poor engraftment and negligible retention in the recipient heart,” PLoS ONE, vol. 9, no. 5, Article ID e96725, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. M. A. Laflamme, K. Y. Chen, A. V. Naumova et al., “Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts,” Nature Biotechnology, vol. 25, no. 9, pp. 1015–1024, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. H. K. Haider and M. Ashraf, “Preconditioning and stem cell survival,” Journal of Cardiovascular Translational Research, vol. 3, no. 2, pp. 89–102, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Mohsin, M. Khan, H. Toko et al., “Human cardiac progenitor cells engineered with Pim-I kinase enhance myocardial repair,” Journal of the American College of Cardiology, vol. 60, no. 14, pp. 1278–1287, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. E. M. Small, R. J. A. Frost, and E. N. Olson, “MicroRNAs add a new dimension to cardiovascular disease,” Circulation, vol. 121, no. 8, pp. 1022–1032, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. D. P. Bartel, “MicroRNAs: genomics, biogenesis, mechanism, and function,” Cell, vol. 116, no. 2, pp. 281–297, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. C. Lv, Y. Hao, and G. Tu, “MicroRNA-21 promotes proliferation, invasion and suppresses apoptosis in human osteosarcoma line MG63 through PTEN/Akt pathway,” Tumor Biology, vol. 37, no. 7, pp. 9333–9342, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. Y. Cheng and C. Zhang, “MicroRNA-21 in cardiovascular disease,” Journal of Cardiovascular Translational Research, vol. 3, no. 3, pp. 251–255, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Anton, S. S. Chatterjee, J. Simundza, P. Cowin, and R. DasGupta, “A systematic screen for micro-RNAs regulating the canonical Wnt pathway,” PLoS ONE, vol. 6, no. 10, Article ID e26257, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. A. M. Fuller and L. Qian, “MiRiad roles for microRNAs in cardiac development and regeneration,” Cells, vol. 3, no. 3, pp. 724–750, 2014. View at Publisher · View at Google Scholar
  31. T. Hosoda, “The mircrine mechanism controlling cardiac stem cell fate,” Frontiers in Genetics, vol. 4, article 204, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. T. Thum, P. Galuppo, C. Wolf et al., “MicroRNAs in the human heart: a clue to fetal gene reprogramming in heart failure,” Circulation, vol. 116, no. 3, pp. 258–267, 2007. View at Publisher · View at Google Scholar · View at Scopus
  33. C. Wei, L. Li, I. K. Kim, P. Sun, and S. Gupta, “NF-κB mediated miR-21 regulation in cardiomyocytes apoptosis under oxidative stress,” Free Radical Research, vol. 48, no. 3, pp. 282–291, 2014. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Lv, Y. Hao, Y. Han et al., “Role and mechanism of microRNA-21 in H2O2-induced apoptosis in bone marrow mesenchymal stem cells,” Journal of Clinical Neuroscience, vol. 27, pp. 154–160, 2016. View at Publisher · View at Google Scholar · View at Scopus
  35. E. van Rooij, L. B. Sutherland, X. Qi, J. A. Richardson, J. Hill, and E. N. Olson, “Control of stress-dependent cardiac growth and gene expression by a microRNA,” Science, vol. 316, no. 5824, pp. 575–579, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. Y. Zhao, E. Samal, and D. Srivastava, “Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis,” Nature, vol. 436, no. 7048, pp. 214–220, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. T. Hosoda, H. Zheng, M. Cabral-Da-Silva et al., “Human cardiac stem cell differentiation is regulated by a mircrine mechanism,” Circulation, vol. 123, no. 12, pp. 1287–1296, 2011. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Wu, Y. Liu, Z. Fan et al., “miR-21 modulates the immunoregulatory function of bone marrow mesenchymal stem cells through the PTEN/Akt/TGF-β1 pathway,” STEM CELLS, vol. 33, no. 11, pp. 3281–3290, 2015. View at Publisher · View at Google Scholar · View at Scopus
  39. A. Richart, X. Loyer, T. Néri et al., “MicroRNA-21 coordinates human multipotent cardiovascular progenitors therapeutic potential,” Stem Cells, vol. 32, no. 11, pp. 2908–2922, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. L. Ciuffreda, I. Falcone, U. C. Incani et al., “PTEN expression and function in adult cancer stem cells and prospects for therapeutic targeting,” Advances in Biological Regulation, vol. 56, pp. 66–80, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. A. R. Panigrahi, S. E. Pinder, S. Y. Chan, E. C. Paish, J. F. R. Robertson, and I. O. Ellis, “The role of PTEN and its signalling pathways, including AKT, in breast cancer; an assessment of relationships with other prognostic factors and with outcome,” The Journal of Pathology, vol. 204, no. 1, pp. 93–100, 2004. View at Publisher · View at Google Scholar · View at Scopus
  42. C. Gregorian, J. Nakashima, J. Le Belle et al., “Pten deletion in adult neural stem/progenitor cells enhances constitutive neurogenesis,” The Journal of Neuroscience, vol. 29, no. 6, pp. 1874–1886, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. K. T. Keyes, J. Xu, B. Long, C. Zhang, Z. Hu, and Y. Ye, “Pharmacological inhibition of PTEN limits myocardial infarct size and improves left ventricular function postinfarction,” American Journal of Physiolog—Heart and Circulatory Physiology, vol. 298, no. 4, pp. H1198–H1208, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. M. M. Mocanu and D. M. Yellon, “PTEN, the Achilles' heel of myocardial ischaemia/reperfusion injury?” British Journal of Pharmacology, vol. 150, no. 7, pp. 833–838, 2007. View at Publisher · View at Google Scholar · View at Scopus
  45. A. C. Schmid, R. D. Byrne, R. Vilar, and R. Woscholski, “Bisperoxovanadium compounds are potent PTEN inhibitors,” FEBS Letters, vol. 566, no. 1–3, pp. 35–38, 2004. View at Publisher · View at Google Scholar
  46. G. Schwartzbauer and J. Robbins, “The tumor suppressor gene PTEN can regulate cardiac hypertrophy and survival,” The Journal of Biological Chemistry, vol. 276, no. 38, pp. 35786–35793, 2001. View at Publisher · View at Google Scholar · View at Scopus
  47. D.-N. Wu, D.-S. Pei, Q. Wang, and G.-Y. Zhang, “Down-regulation of PTEN by sodium orthovanadate inhibits ASK1 activation via PI3-K/Akt during cerebral ischemia in rat hippocampus,” Neuroscience Letters, vol. 404, no. 1-2, pp. 98–102, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. V. Stambolic, A. Suzuki, J. L. De la Pompa et al., “Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN,” Cell, vol. 95, no. 1, pp. 29–39, 1998. View at Publisher · View at Google Scholar · View at Scopus
  49. W. Qi, H. Li, X.-H. Cai et al., “Lipoxin A4 activates alveolar epithelial sodium channel gamma via the microRNA-21/PTEN/AKT pathway in lipopolysaccharide-induced inflammatory lung injury,” Laboratory Investigation, vol. 95, no. 11, pp. 1258–1268, 2015. View at Publisher · View at Google Scholar · View at Scopus
  50. J. Li, C. Yen, D. Liaw et al., “PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer,” Science, vol. 275, no. 5308, pp. 1943–1947, 1997. View at Publisher · View at Google Scholar · View at Scopus
  51. F. Meng, R. Henson, M. Lang et al., “Involvement of human micro-RNA in growth and response to chemotherapy in human cholangiocarcinoma cell lines,” Gastroenterology, vol. 130, no. 7, pp. 2113–2129, 2006. View at Publisher · View at Google Scholar · View at Scopus
  52. A. Di Cristofano and P. P. Pandolfi, “The multiple roles of PTEN in tumor suppression,” Cell, vol. 100, no. 4, pp. 387–390, 2000. View at Publisher · View at Google Scholar · View at Scopus
  53. H. Bai, R. Xu, Z. Cao, D. Wei, and C. Wang, “Involvement of miR-21 in resistance to daunorubicin by regulating PTEN expression in the leukaemia K562 cell line,” FEBS Letters, vol. 585, no. 2, pp. 402–408, 2011. View at Publisher · View at Google Scholar · View at Scopus
  54. B. Yan-Nan, Y. Zhao-Yan, L. Li-Xi, X. Qing-Jie, and Z. Yong, “MicroRNA-21 accelerates hepatocyte proliferation in vitro via PI3K/Akt signaling by targeting PTEN,” Biochemical and Biophysical Research Communications, vol. 443, no. 3, pp. 802–807, 2014. View at Publisher · View at Google Scholar
  55. H. Ou, Y. Li, and M. Kang, “Activation of miR-21 by STAT3 induces proliferation and suppresses apoptosis in nasopharyngeal carcinoma by targeting PTEN gene,” PLoS ONE, vol. 9, no. 11, Article ID e109929, 2014. View at Publisher · View at Google Scholar · View at Scopus
  56. D. Sayed, M. He, C. Hong et al., “MicroRNA-21 is a downstream effector of AKT that mediates its antiapoptotic effects via suppression of fas ligand,” The Journal of Biological Chemistry, vol. 285, no. 26, pp. 20281–20290, 2010. View at Publisher · View at Google Scholar · View at Scopus
  57. Y. Tu, L. Wan, Y. Fan et al., “Ischemic postconditioning-mediated miRNA-21 protects against cardiac ischemia/reperfusion injury via PTEN/Akt pathway,” PLoS ONE, vol. 8, no. 10, Article ID e75872, 2013. View at Publisher · View at Google Scholar · View at Scopus
  58. S. H. Choi, S. Y. Jung, W. Suh, S. H. Baek, and S.-M. Kwon, “Establishment of isolation and expansion protocols for human cardiac C-kit-positive progenitor cells for stem cell therapy,” Transplantation Proceedings, vol. 45, no. 1, pp. 420–426, 2013. View at Publisher · View at Google Scholar · View at Scopus
  59. A. Kazakov, T. Meier, C. Werner et al., “C-kit+ resident cardiac stem cells improve left ventricular fibrosis in pressure overload,” Stem Cell Research, vol. 15, no. 3, pp. 700–711, 2015. View at Publisher · View at Google Scholar · View at Scopus
  60. S. Cao, Y. Liu, W. Sun et al., “Genome-wide expression profiling of anoxia/reoxygenation in rat cardiomyocytes uncovers the role of mito KATP in energy homeostasis,” Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 756576, 14 pages, 2015. View at Publisher · View at Google Scholar · View at Scopus
  61. Y. Cheng, X. Liu, S. Zhang, Y. Lin, J. Yang, and C. Zhang, “MicroRNA-21 protects against the H2O2-induced injury on cardiac myocytes via its target gene PDCD4,” Journal of Molecular & Cellular Cardiology, vol. 47, no. 1, pp. 5–14, 2009. View at Publisher · View at Google Scholar · View at Scopus
  62. E. Di Bernardini, P. Campagnolo, A. Margariti et al., “Endothelial Lineage differentiation from induced pluripotent stem cells is regulated by microRNA-21 and transforming growth factor β2 (TGF-β2) pathways,” The Journal of Biological Chemistry, vol. 289, no. 6, pp. 3383–3393, 2014. View at Publisher · View at Google Scholar · View at Scopus
  63. S. Cao, Y. Liu, H. Wang et al., “Ischemic postconditioning influences electron transport chain protein turnover in Langendorff-perfused rat hearts,” PeerJ, vol. 4, Article ID e1706, 2016. View at Publisher · View at Google Scholar
  64. P. Nigro, G. L. Perrucci, A. Gowran, M. Zanobini, M. C. Capogrossi, and G. Pompilio, “c-kit+ cells: the tell-tale heart of cardiac regeneration?” Cellular & Molecular Life Sciences, vol. 72, no. 9, pp. 1725–1740, 2015. View at Publisher · View at Google Scholar · View at Scopus
  65. J. Xiao, Y. Pan, X. H. Li et al., “Cardiac progenitor cell-derived exosomes prevent cardiomyocytes apoptosis through exosomal miR-21 by targeting PDCD4,” Cell Death & Disease, vol. 7, no. 6, Article ID e2277, 2016. View at Publisher · View at Google Scholar
  66. Y. Lin, X. Liu, Y. Cheng, J. Yang, Y. Huo, and C. Zhang, “Involvement of MicroRNAs in hydrogen peroxide-mediated gene regulation and cellular injury response in vascular smooth muscle cells,” The Journal of Biological Chemistry, vol. 284, no. 12, pp. 7903–7913, 2009. View at Publisher · View at Google Scholar · View at Scopus
  67. X. Xu, A. J. Kriegel, X. Jiao et al., “miR-21 in ischemia/reperfusion injury: a double-edged sword?” Physiological Genomics, vol. 46, no. 21, pp. 789–797, 2014. View at Publisher · View at Google Scholar · View at Scopus
  68. M. Sussman, “‘AKT’ing lessons for stem cells: regulation of cardiac myocyte and progenitor cell proliferation,” Trends in Cardiovascular Medicine, vol. 17, no. 7, pp. 235–240, 2007. View at Publisher · View at Google Scholar · View at Scopus
  69. P. Yang, J. J. Peairs, R. Tano, and G. J. Jaffe, “Oxidant-mediated Akt activation in human RPE cells,” Investigative Ophthalmology & Visual Science, vol. 47, no. 10, pp. 4598–4606, 2006. View at Publisher · View at Google Scholar · View at Scopus
  70. S. H. Byeon, S. C. Lee, S. H. Choi et al., “Vascular endothelial growth factor as an autocrine survival factor for retinal pigment epithelial cells under oxidative stress via the VEGF-R2/PI3K/Akt,” Investigative Ophthalmology & Visual Science, vol. 51, no. 2, pp. 1190–1197, 2010. View at Publisher · View at Google Scholar · View at Scopus
  71. L.-L. Mao, D.-L. Hao, X.-W. Mao et al., “Neuroprotective effects of bisperoxovanadium on cerebral ischemia by inflammation inhibition,” Neuroscience Letters, vol. 602, pp. 120–125, 2015. View at Publisher · View at Google Scholar · View at Scopus
  72. D.-F. Wang, H.-J. Yang, J.-Q. Gu et al., “Suppression of phosphatase and tensin homolog protects insulin-resistant cells from apoptosis,” Molecular Medicine Reports, vol. 12, no. 2, pp. 2695–2700, 2015. View at Publisher · View at Google Scholar
  73. G. Gabriely, T. Wurdinger, S. Kesari et al., “MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators,” Molecular & Cellular Biology, vol. 28, no. 17, pp. 5369–5380, 2008. View at Publisher · View at Google Scholar · View at Scopus